ArticleMolecular biology reports2025
A 15 bp non-canonical splice-site deletion in ABCA4 linked with retinitis pigmentosa and myopia: insights into splicing defects and phenotypic variability.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundPresent study aimed to identify the underlying genetic defect for autosomal recessive retinitis pigmentosa (arRP) with moderate myopia (-3.0D to -5.0D) in a North Indian family.
methodsFamily history and clinical data were collected from all the available affected and unaffected members of an arRP family and a pedigree was drawn. Whole genome homozygosity mapping using SNP markers was performed, and variants were prioritized. Further, the potential pathogenic variant detected in the proband was tested for familial segregation by Sanger sequencing.
resultsA 15 bp non-canonical splice-site (NCSS) deletion (c.6729 + 5_6729 + 19del) in intron 48 of ABCA4 was observed that co-segregated with the phenotype in all the affected members of the family. The clinically tested unaffected family members were either heterozygous or wild-type homozygous for the observed 15 bp NCSS deletion. The identified change was not detected in 100 ethnically matched controls, hence excluding it as a polymorphism. Bioinformatics analysis indicated that due to this 15 bp non-canonical splice-site deletion there occurred a loss of predicted RNA-binding motifs for heterogeneous nuclear ribonucleoproteins (hnRNPs H1, H2, H3, F) and Y box binding protein 1 (YB-1), which are essential for normal RNA splicing, hence suggesting aberrant splicing in the patients.
conclusionsThe present study identified a 15 bp NCSS deletion (c.6729 + 5_6729 + 19del) in intron 48 of ABCA4 linked with arRP and moderate myopia. This pathogenic ABCA4 variant is predicted to cause the loss of binding sites for hnRNPs and YB-1 proteins which play crucial role in normal splicing, hence might result in alternative splicing. The identified 15 bp NCSS deletion has previously been reported in isolated cases of cone-rod dystrophy, early-onset severe retinal dystrophy and Stargardt's disease. The patients in the present study showed typical features of RP and myopia, indicating phenotypic variability as compared to the previous reports.
Indexed as
Identifiers
41003791What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.